Evidence map›Paper›PMID 38911536›Full record

ArticleToxicological research2024

Risk assessment of cyclohexasiloxane D6 in cosmetic products.

Yeonju Ko, Donghyeon Lim, Hyunjoon Choi, Seongwon Choi, Shinai Choi, Jiyeon Hong, Young A Yoon, Hyun Chung, Kyung-Min Lim, Kyu-Bong Kim and 3 more

Abstract read
In one paragraph

Article in Toxicological research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Safety Assessment ofToxics · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yeonju KoCollege of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University ERICA, Ansan, 15588 Korea.
Donghyeon LimCollege of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University ERICA, Ansan, 15588 Korea.
Hyunjoon ChoiCollege of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University ERICA, Ansan, 15588 Korea.
Seongwon ChoiCollege of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University ERICA, Ansan, 15588 Korea.
Shinai ChoiKnA Co., Ltd., Yongin, 17027 Korea.
Jiyeon HongKnA Co., Ltd., Yongin, 17027 Korea.
Young A YoonKnA Co., Ltd., Yongin, 17027 Korea.
Hyun ChungKnA Co., Ltd., Yongin, 17027 Korea.
Kyung-Min LimCollege of Pharmacy, Ewha Womans University, Seoul, 03760 Korea.
Kyu-Bong KimCollege of Pharmacy, Dankook University, Cheonan, 31116 Chungnam Korea.
Joo Young LeeCollege of Pharmacy, The Catholic University of Korea, Bucheon, 14662 Korea.
Seung Jun KwackCollege of Natural Sciences, Changwon National University, Changwon, 51140 Gyeongnam Korea.
Ok-Nam BaeCollege of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University ERICA, Ansan, 15588 Korea.ORCID 0000-0003-0583-2116

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dodecamethylcyclohexasiloxane (D6) is a siloxane substance mainly used in cosmetics and personal care products. While octamethylcyclotetrasiloxane (D4) and decamethylcyclopentasiloxane (D5) were once commonly used in personal care products, their usage has been restricted due to the classification as persistent, bioaccumulative, and toxic (PBT)/very persistent and very bio-accumulative (vPvB) substances. While D6 has emerged as a substitute for D4 and D5, the risk assessment for D6 remains limited compared to the evaluations for D4 and D5. To address this gap, we conducted a comprehensive risk assessment of D6. In this study, we reviewed the toxicity information on D6 and calculated the exposure level to D6, considering the content of D6 in cosmetic products. No observed adverse effect level (NOAEL) of 1500 mg/kg bw/day was established in a repeated dose toxicity study after oral administration to rats. Negative results were found in tests on the ocular and skin irritation, skin sensitization, and genotoxicity of D6. According to the product content of up to 48% of D6 reported in 2012, the Systemic Exposure Dose (SED) was 5.4E-06 to 7.04 mg/kg bw/day for a 60 kg adult using the exposure factors from Korean cosmetic usage. The Margin of Safety was estimated to be between 35.5 and 4.63E+07, posing a potential health risk of D6 according to the maximum concentration and the product type. Further consideration of the potential of D6 as PBT or vPvB is also required.

Indexed as

Cosmetic productsCyclohexasiloxaneD6DodecamethylcyclohexasiloxaneRisk assessment

Identifiers

PMID38911536
PMCPMC11187014

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.